Clear Search sequence regions


  • angiogenesis (1)
  • ENG (14)
  • Erk1 (1)
  • growth factor (2)
  • Kdr (1)
  • MEK1 2 (1)
  • mice (1)
  • NRP1 (11)
  • receptor igg (1)
  • receptors (4)
  • signal (1)
  • vascular factor (2)
  • VEGF (8)
  • VEGFR2 (9)
  • Sizes of these terms reflect their relevance to your search.

    Endothelial cells express neuropilin 1 (NRP1), endoglin (ENG) and vascular endothelial growth factor receptor 2 (VEGFR2), which regulate VEGF-A-mediated vascular development and angiogenesis. However, the link between complex formation among these receptors with VEGF-A-induced signaling and biology is yet unclear. Here, we quantify surface receptor interactions by IgG-mediated immobilization of one receptor, and fluorescence recovery after photobleaching (FRAP) measurements of the mobility of another coexpressed receptor. We observe stable ENG/NRP1, ENG/VEGFR2, and NRP1/VEGFR2 complexes, which are enhanced by VEGF-A. ENG augments NRP1/VEGFR2 interactions, suggesting formation of tripartite complexes bridged by ENG. Effects on signaling are measured in murine embryonic endothelial cells expressing (MEEC+/+) or lacking (MEEC-/-) ENG, along with NRP1 and/or ENG overexpression or knockdown. We find that optimal VEGF-A-mediated phosphorylation of VEGFR2 and Erk1/2 requires ENG and NRP1. ENG or NRP1 increase VEGF-A-induced sprouting, becoming optimal in cells expressing all three receptors, and both processes are inhibited by a MEK1/2 inhibitor. We propose a model where the maximal potency of VEGF-A involves a tripartite complex where ENG bridges VEGFR2 and NRP1, providing an attractive therapeutic target for modulation of VEGF-A signaling and biological responses. © 2024. The Author(s).

    Citation

    Swati Sharma, Marcelo Ehrlich, Manqi Zhang, Gerard C Blobe, Yoav I Henis. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting. Communications biology. 2024 Jan 19;7(1):112

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38242992

    View Full Text